183 related articles for article (PubMed ID: 29693804)
1. Synergistic Growth Inhibitory Effects of Chrysin and Metformin Combination on Breast Cancer Cells through hTERT and Cyclin D1 Suppression.
Rasouli S; Zarghami N
Asian Pac J Cancer Prev; 2018 Apr; 19(4):977-982. PubMed ID: 29693804
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Anti-proliferative Effects of Metformin and Silibinin Combination on T47D Breast Cancer Cells via hTERT and Cyclin D1 Inhibition.
Chatran M; Pilehvar-Soltanahmadi Y; Dadashpour M; Faramarzi L; Rasouli S; Jafari-Gharabaghlou D; Asbaghi N; Zarghami N
Drug Res (Stuttg); 2018 Dec; 68(12):710-716. PubMed ID: 29920623
[TBL] [Abstract][Full Text] [Related]
3. MPEG-PCL Nanomicelles Platform for Synergistic Metformin and Chrysin Delivery to Breast Cancer in Mice.
Luo D; Wang X; Zhong X; Chang J; He M; Wang H; Li Y; Zhao C; Luo Y; Ran L
Anticancer Agents Med Chem; 2022; 22(2):280-293. PubMed ID: 34165412
[TBL] [Abstract][Full Text] [Related]
4. Metformin promotes apoptosis in primary breast cancer cells by downregulation of cyclin D1 and upregulation of P53 through an AMPK-alpha independent mechanism.
Yenmiş G; Beşli N; Yaprak Saraç E; Hocaoğlu Emre FS; Şenol K; Kanıgür G
Turk J Med Sci; 2021 Apr; 51(2):826-834. PubMed ID: 33350292
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Dual Bioactive Compounds Artemisinin and Metformin Co-loaded in PLGA-PEG Nano-particles on Breast Cancer Cell lines: Potential Apoptotic and Anti-proliferative Action.
Hassani N; Jafari-Gharabaghlou D; Dadashpour M; Zarghami N
Appl Biochem Biotechnol; 2022 Oct; 194(10):4930-4945. PubMed ID: 35674922
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells.
Javan Maasomi Z; Pilehvar Soltanahmadi Y; Dadashpour M; Alipour Sh; Abolhasani S; Zarghami N
Asian Pac J Cancer Prev; 2017 May; 18(5):1283-1287. PubMed ID: 28610415
[TBL] [Abstract][Full Text] [Related]
7. Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells.
Farajzadeh R; Pilehvar-Soltanahmadi Y; Dadashpour M; Javidfar S; Lotfi-Attari J; Sadeghzadeh H; Shafiei-Irannejad V; Zarghami N
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):917-925. PubMed ID: 28678551
[TBL] [Abstract][Full Text] [Related]
8. Metformin Modulates Cyclin D1 and P53 Expression to Inhibit Cell Proliferation and to Induce Apoptosis in Cervical Cancer Cell Lines.
Yudhani RD; Astuti I; Mustofa M; Indarto D; Muthmainah M
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1667-1673. PubMed ID: 31244286
[TBL] [Abstract][Full Text] [Related]
9. Development of PEGylated PLGA Nanoparticles Co-Loaded with Bioactive Compounds: Potential Anticancer Effect on Breast Cancer Cell Lines.
Mohammadinejad S; Jafari-Gharabaghlou D; Zarghami N
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4063-4072. PubMed ID: 36579986
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.
Peek GW; Tollefsbol TO
Exp Cell Res; 2016 May; 344(1):95-102. PubMed ID: 27017931
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Effect of Free and Nano-encapsulated Chrysin-Curcumin on Inhibition of hTERT Gene Expression in SW480 Colorectal Cancer Cell Line.
Bagheri R; Sanaat Z; Zarghami N
Drug Res (Stuttg); 2018 Jun; 68(6):335-343. PubMed ID: 29294495
[TBL] [Abstract][Full Text] [Related]
12. Design and Development of Nanostructured Co Delivery of Artemisinin and Chrysin for Targeting hTERT Gene Expression in Breast Cancer Cell Line: Possible Clinical Application in Cancer Treatment.
Khoshravan L; Dadashpour M; Hashemi M; Zarghami N
Asian Pac J Cancer Prev; 2022 Mar; 23(3):919-927. PubMed ID: 35345364
[TBL] [Abstract][Full Text] [Related]
13. Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells.
Nasiri M; Zarghami N; Koshki KN; Mollazadeh M; Moghaddam MP; Yamchi MR; Esfahlan RJ; Barkhordari A; Alibakhshi A
Asian Pac J Cancer Prev; 2013; 14(6):3449-53. PubMed ID: 23886126
[TBL] [Abstract][Full Text] [Related]
14. Fangchinoline inhibits cell proliferation via Akt/GSK-3beta/ cyclin D1 signaling and induces apoptosis in MDA-MB-231 breast cancer cells.
Wang CD; Yuan CF; Bu YQ; Wu XM; Wan JY; Zhang L; Hu N; Liu XJ; Zu Y; Liu GL; Song FZ
Asian Pac J Cancer Prev; 2014; 15(2):769-73. PubMed ID: 24568493
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of chrysin and radiotherapy against triple-negative breast cancer (TNBC) cell lines.
Jafari S; Dabiri S; Mehdizadeh Aghdam E; Fathi E; Saeedi N; Montazersaheb S; Farahzadi R
Clin Transl Oncol; 2023 Aug; 25(8):2559-2568. PubMed ID: 36964888
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
[TBL] [Abstract][Full Text] [Related]
17. Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer.
Gwak H; Kim Y; An H; Dhanasekaran DN; Song YS
Mol Carcinog; 2017 Feb; 56(2):349-358. PubMed ID: 27128966
[TBL] [Abstract][Full Text] [Related]
18. Preparation and Evaluation of Chrysin Encapsulated in PLGA- PEG Nanoparticles in the T47-D Breast Cancer Cell Line.
Mohammadinejad S; Akbarzadeh A; Rahmati-Yamchi M; Hatam S; Kachalaki S; Zohreh S; Zarghami N
Asian Pac J Cancer Prev; 2015; 16(9):3753-8. PubMed ID: 25987033
[TBL] [Abstract][Full Text] [Related]
19. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
[TBL] [Abstract][Full Text] [Related]
20. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
